Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Magnuson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the National Cancer Institute|January 2, 2017
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate CancerNataniel H Lester-Coll, Skyler Johnson, William J Magnuson, et al.
Cancer|May 21, 2016
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockersZachary S Morris, Sandeep Saha, William J Magnuson, et al.
Radiation Oncology (London, England)|May 31, 2013
Survival following gamma knife radiosurgery for brain metastasis from breast cancerJerry J Jaboin, Daniel J Ferraro, Todd A DeWees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional AnalysisWilliam J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the National Cancer Institute|January 2, 2017
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate CancerNataniel H Lester-Coll, Skyler Johnson, William J Magnuson, et al.
Cancer|May 21, 2016
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockersZachary S Morris, Sandeep Saha, William J Magnuson, et al.
Radiation Oncology (London, England)|May 31, 2013
Survival following gamma knife radiosurgery for brain metastasis from breast cancerJerry J Jaboin, Daniel J Ferraro, Todd A DeWees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional AnalysisWilliam J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, et al.
Pageof 2